ArticleJACC. Case reports2026
Transaxillary Transcatheter Aortic Valve Replacement: A Technical Narrative.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTranscatheter aortic valve replacement (TAVR) valve delivery is usually achieved transfemorally. Unfavorable iliofemoral anatomy can preclude transfemoral valve delivery, and alternative arterial access should be considered. We describe our preferred technique in transaxillary TAVR. KEY STEPS: 1) Radial or femoral arterial access for pigtail catheter placement; 2) femoral venous access for temporary pacemaker placement; 3) axillary artery exposure, control, and access; 4) root aortography; 5) aortic valve crossing; 6) advancement of the valve delivery system; 7) valve deployment; and 8) removal of the valve delivery system, repair of the axillary arteriotomy, and wound closure. POTENTIAL PITFALLS: 1) Arterial access site bleeding or stenosis; 2) arterial thrombosis; 3) axillary artery dissection; and 4) significant atherosclerosis interfering with arteriotomy repair. TAKE-HOME MESSAGE: Transaxillary arterial access for TAVR is a safe alternative valve delivery route, should be considered the first alternate access choice, and provides an efficient, effective, and reproducible technique when transfemoral access is prohibitive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.